Autonomix Medical increases ATM equity offering by $1.4M to $3.5M aggregate

Autonomix Medical, Inc.

Increased at-market issuance sales agreement with Ladenburg Thalmann by $1.4 million; total shares may now be sold up to $3.5 million aggregate price.
Sales made under effective shelf registration statement on Form S-3 (File No. 333-285464), effective March 11, 2025.
No other events disclosed; proceeds intended for general corporate purposes.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.